These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 1675468

  • 1. Oncogene abnormalities in astrocytomas: EGF-R gene alone appears to be more frequently amplified and rearranged compared with other protooncogenes.
    Burgart LJ, Robinson RA, Haddad SF, Moore SA.
    Mod Pathol; 1991 Mar; 4(2):183-6. PubMed ID: 1675468
    [Abstract] [Full Text] [Related]

  • 2. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
    Zhang X, Silva E, Gershenson D, Hung MC.
    Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
    [Abstract] [Full Text] [Related]

  • 3. Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.
    Weidner U, Peter S, Strohmeyer T, Hussnätter R, Ackermann R, Sies H.
    Cancer Res; 1990 Aug 01; 50(15):4504-9. PubMed ID: 1973362
    [Abstract] [Full Text] [Related]

  • 4. Genomic alterations in sarcomas: a histologic correlative study with use of oncogene panels.
    Maillet MW, Robinson RA, Burgart LJ.
    Mod Pathol; 1992 Jul 01; 5(4):410-4. PubMed ID: 1495946
    [Abstract] [Full Text] [Related]

  • 5. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H.
    Cell Growth Differ; 1990 Sep 01; 1(9):407-20. PubMed ID: 1981145
    [Abstract] [Full Text] [Related]

  • 6. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
    Shiraishi M, Noguchi M, Shimosato Y, Sekiya T.
    Cancer Res; 1989 Dec 01; 49(23):6474-9. PubMed ID: 2573414
    [Abstract] [Full Text] [Related]

  • 7. ERBB2 (HER2/neu) oncogene is frequently amplified in squamous cell carcinoma of the uterine cervix.
    Mitra AB, Murty VV, Pratap M, Sodhani P, Chaganti RS.
    Cancer Res; 1994 Feb 01; 54(3):637-9. PubMed ID: 7905784
    [Abstract] [Full Text] [Related]

  • 8. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M, Mattern J.
    Anticancer Res; 1993 Feb 01; 13(6A):2021-5. PubMed ID: 8297109
    [Abstract] [Full Text] [Related]

  • 9. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I, Dietrich PY, Aapro M, Vauthier G, Vadas L, Engel E.
    Cancer Res; 1989 Dec 01; 49(23):6675-9. PubMed ID: 2573420
    [Abstract] [Full Text] [Related]

  • 10. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP, Castillo SG, Nguyen CV, Hickey RC, Samaan NA.
    Anticancer Res; 1990 Dec 01; 10(1):189-92. PubMed ID: 2185686
    [Abstract] [Full Text] [Related]

  • 11. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ, Frierson HF, Williams ME.
    Mod Pathol; 1993 Nov 01; 6(6):654-9. PubMed ID: 7905628
    [Abstract] [Full Text] [Related]

  • 12. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
    Hauguel-DeMouzon S, Csermely P, Zoppini G, Kahn CR.
    J Cell Physiol; 1992 Jan 01; 150(1):180-7. PubMed ID: 1730782
    [Abstract] [Full Text] [Related]

  • 13. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T.
    Anticancer Res; 1989 Jan 01; 9(6):1537-47. PubMed ID: 2697181
    [Abstract] [Full Text] [Related]

  • 14. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ, Ince C, Rosenblum MG, Gallick GE.
    J Cell Biochem; 1989 Nov 01; 41(3):139-57. PubMed ID: 2482293
    [Abstract] [Full Text] [Related]

  • 15. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M, Efferth T, Mattern J.
    Anticancer Res; 1992 Nov 01; 12(1):11-20. PubMed ID: 1348920
    [Abstract] [Full Text] [Related]

  • 16. The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).
    Lavialle C, Modjtahedi N, Lamonerie T, Frebourg T, Landin RM, Fossar N, Lhomond G, Cassingena R, Brison O.
    Anticancer Res; 1989 Nov 01; 9(5):1265-79. PubMed ID: 2686529
    [Abstract] [Full Text] [Related]

  • 17. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
    Okimoto T, Kohno K, Kuwano M, Gopas J, Kung HF, Ono M.
    Oncogene; 1996 Apr 18; 12(8):1625-33. PubMed ID: 8622882
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Transcriptional control of the protooncogenes--human EGF receptor gene and c-Ha-ras 1 gene].
    Ishii S.
    Tanpakushitsu Kakusan Koso; 1986 Jul 18; 31(8):681-92. PubMed ID: 3538192
    [No Abstract] [Full Text] [Related]

  • 20. Amplification of the int-2 gene in human head and neck squamous cell carcinomas.
    Somers KD, Cartwright SL, Schechter GL.
    Oncogene; 1990 Jun 18; 5(6):915-20. PubMed ID: 2193294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.